# REGENXBIO INC (RGNX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RGNX/

- Reporting holders: 4
- Reported value: $47.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $20.6K | 2,741 | 0.0% | 17 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $18.0K | 2,387 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $5.7K | 754 | 0.0% | 5 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $2.8K | 370 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $47.1K |
| Q2 2026 | 169 | $568.6M |
| Q1 2026 | 179 | $363.9M |
| Q4 2025 | 176 | $599.6M |
| Q3 2025 | 167 | $442.4M |
| Q2 2025 | 162 | $348.0M |
| Q1 2025 | 165 | $300.6M |
| Q4 2024 | 177 | $327.2M |
| Q3 2024 | 186 | $492.2M |
| Q2 2024 | 181 | $549.1M |
| Q1 2024 | 192 | $1.0B |
| Q4 2023 | 171 | $791.8M |